Stock market quotes, forex, financial news, forex tools – money-investing.com

Pfizer completely changes its business model

 Breaking News
  • US Ministry of Energy predicts reduction of oil prices The US Ministry of Energy has published a monthly report, which turned out to be discouraging. It is expected that in the last quarter of this year the price for...
  • 28 Chinese companies are blacklisted by the US Everyone knows that just in few days two powerful states China and the USA – are starting the next round of the negotiations. Official Beijing has announced that it is...
  • Startup WeWork again in spotlight We have been writing about the startup WeWork, which was forced to postpone the initial public offering. They earn by renting commercial space for a long time in order to...
  • Massive cuts in HSBC HSBC Holdings Plc, the largest bank in Europe and one of the most significant and serious players in the global financial market, has announced the launch of a cost-optimization program....
  • Oil quotes still wait for negotiations Today, at 8.15 a.m. Moscow time, futures for Brent crude oil were trading in London for $ 58.31 per barrel. This is only 0.1% below the closing price of the...
Pfizer completely changes its business model
July 11
09:00 2018

Pfizer Inc, the world’s largest research-based pharmaceutical company, has announced that it is going to reorganize its own business model. According to the management, before the end of the year it will be decided to set up a unit that produces drugs, which do not require prescriptions. Such drugs belong to the category of consumer medicines.

Pfizer will work in three main areas – the production of innovative drugs, consumer medications (including those that are sold without a prescription) and the company’s main drugs, including Viagra and Lipitor. According to the reports, innovative and consumer medicines bring the company 3/4 of its total revenue. So the upcoming changes look quite logical. Changes in the work scheme will occur next year.

Management is seriously working on developing the business of consumer products, for which a prescription is not needed. There have been discussions for several months and if differences persist, the sale of business may become the final decision.

Pfizer recently stated that the increase in the medicine tariffs would be postponed. This will give the government time to implement a health reform. In a sense, US President D. Trump had a hand in this pause. He held a meeting with the company’s CEO Chris J. Reed.

This year, the value of the company has increased by 3% and amounted to 219 billion US dollars. But during the bidding process on Wednesday, the company’s shares fell by almost 0.5 %.

 

The material was prepared with the participation of Anjela Chromova,
a leading analyst of the brokerage company CT Trade

Related Articles

1 Comment

  1. Elroy Lukow
    Elroy Lukow July 30, 06:15

    Thank you for all your hard work on this blog. My niece takes pleasure in participating in research and it’s easy to see why. We all hear all regarding the compelling means you offer important guidelines through the website and boost response from other ones on this article then our own girl has always been discovering a lot of things. Have fun with the rest of the new year. Your conducting a fantastic job.

    Reply to this comment

Write a Comment